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Introduction
Coronary heart disease (CHD) is one of the main 
cardiovascular diseases and a major cause of death 
globally. In international comparison CHD mortality 
has been very high in Finland, especially among men 
born in Eastern Finland who had globally the highest 
CHD mortality in the 1960s [1] through 1980s [2]. 
A national program – the North Karelia Project – 
was launched in the 1970s to tackle this problem and 
decrease the CHD risk factor levels and mortality 
rate [3].
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Abstract
Aims: Eastern Finns have higher risk of coronary heart disease (CHD) and carotid intima-media thickness than western 
Finns although current differences in CHD risk factors are minimal. Left ventricular (LV) mass and diastolic function 
predict future cardiovascular events but their east–west differences are unknown. We examined the association of eastern/
western baseline origin with LV mass and diastolic function. Methods : The study population included 2045 subjects of 
the Cardiovascular Risk in Young Finns Study with data from the baseline survey (1980) and the latest follow-up (2011) 
when echocardiography was performed at the age of 34–49 years. Results: Subjects with eastern baseline origin had in 2011 
higher LV mass (139±1.0 vs. 135±1.0 g, p=0.006) and E/e′-ratio indicating weaker LV diastolic function (4.86±0.03 vs. 
4.74±0.03, p=0.02) than western subjects. Results were independent of age, sex, area of examination and CHD risk factors 
such as blood pressure and BMI (LV mass indexed with height: p<0.0001; E/e′-ratio: p=0.01). LV end-diastolic volume was 
higher among subjects with eastern baseline origin (135±0.9 vs. 131±0.9 ml, p=0.0011) but left atrial end-systolic volume, 
also indicating LV diastolic function, was not different between eastern and western subjects (43.4±0.5 vs. 44.0±0.5 ml, 
p=0.45). Most of the subjects were well within the normal limits of these echocardiographic measurements. Conclusions: 
In our healthy middle-aged population, geographic origin in eastern Finland associated with higher LV mass 
compared to western Finland. Higher E/e′-ratio suggests that subjects with eastern baseline origin might have 
higher prevalence of diastolic dysfunction in the future than western subjects.
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The Cardiovascular Risk in Young Finns Study 
(Young Finns Study) is a nationwide on-going study 
that has investigated Finnish children and adoles-
cents since 1980 for atherosclerosis precursors 
(n=3596). One of the key purposes of the Young 
Finns Study has been to study differences in CHD 
risk between eastern and western Finns. In the fol-
low-up conducted in 2007, subjects residing in east-
ern Finland had higher blood pressure and 
intima-media thickness (IMT) than western subjects 
[4]. In spite of east–west differences in CHD risk fac-
tors disappearing, 35–64 years old eastern Finns still 
have 20% higher CHD mortality than western Finns 
of the same age (National Institute for Health and 
Welfare; data from year 2012).
Left ventricular (LV) mass and LV hypertrophy 
are important indicators of future cardiovascular 
events [5–7]. LV diastolic dysfunction is thought to 
be a prominent part of the heart failure presenting 
insufficient diastolic suction, impaired relaxation, as 
well as disturbed compliance and stiffness properties 
of the left ventricle [8,9]. E/e′-ratio describing LV 
flow velocity compared to myocardial tissue velocity 
is a marker for LV diastolic function [10] and possi-
bly an earlier indicator of decrease in diastolic func-
tion than the volume of left atrium (LA) [11,12].
In this study we investigated the previously unex-
plored association of eastern/western baseline origin 
with LV mass and diastolic function later in life 
among the Young Finns Study subjects. We also 
investigated east–west differences in these measures 
according eastern/western current residency and 
family origin. We hypothesized subjects with geo-
graphic origin in the east present higher LV mass and 
weaker diastolic function than their western counter-
parts, partly explaining their higher CHD mortality.
Material and methods
Subjects
The Young Finns Study was launched in 1980 to 
examine risk factors underlying cardiovascular dis-
eases [13]. In total, 3596 subjects 3–18 years of age 
were randomly chosen from the national population 
register to be the first cross-sectional survey. In the 
baseline study and every follow-up, the subjects have 
been examined at five study centers in Finland (uni-
versity hospital cities Turku, Helsinki, Tampere, 
Kuopio and Oulu, and their rural vicinities). We used 
data from the baseline survey in 1980 and the latest 
31-year follow-up survey in 2011, where 2045 of the 
original subjects aged 34–49 years took part. 
Echocardiography was conducted in the 2011 fol-
low-up for 1994 participants [14].
The ethics committees of each study center have 
approved the study and all subjects/their parents have 
given their written informed consents.
Definition of geographic origin
Subjects of this Caucasian population were com-
pared according to their baseline origin (1980), cur-
rent residency (2011) or family origin. Subjects were 
determined according to their study center either as 
eastern (Oulu and Kuopio) or western (Turku, 
Helsinki and Tampere) [15]. Geographically more 
correct terms would be northeastern and southwest-
ern Finns, but the terms eastern and western are 
commonly used due to historical and simplicity rea-
sons. Family origin was assessed by the subjects’ 
grandparents’ place of birth and was considered east-
ern if all four grandparents were born in eastern 
Finland (37%) and western if three or four grandpar-
ents were born in western Finland (20%). Data of 
grandparents’ birthplace was incomplete in 26% of 
subjects and they were excluded from family origin 
categorization. Proportions of men and women were 
similar between eastern or western participants. The 
study population consists of white Caucasians.
Echocardiography
Echocardiography was introduced to the Young Finns 
Study in the latest follow-up in 2011. Echocardiographic 
measurements and analysis were performed according 
to EAE/ASE guidelines [10,14,16]. The sonographers 
in all study locations were trained by a cardiac imaging 
specialist. Transthoracic echocardiography was per-
formed with Acuson Sequoia 512 (Acuson, Mountain 
View, CA, USA) ultrasonography, using a 3.5 MHz 
scanning frequency phased-array transducer. Analysis 
of the echo images was carried out by one observer 
using the ComPACS 10.7.8 (MediMatic Solutions, 
Genova, Italy) analysis program. Both the sonographer 
and the observer were blind to the subjects’ details.
Echocardiographic examinations were produced 
from the standardized image planes and modes: par-
asternal long and short axis in 2D and M mode and 
apical four chamber view as described earlier [14]. 
Briefly, the LV end-diastolic and end-systolic vol-
umes were measured from the apical 4-chamber view 
based on the recommendations to assess ejection 
fraction [10, 16], which was calculated as follows: 
Ejection fraction = 100 × (LV end-diastolic volume 
– LV end-systolic volume) / LV end-diastolic 
volume.
LV mass was calculated as follows: (0.8 × [1.04 × 
(LV end-diastolic diameter + posterior wall thickness + 
interventricular septum thickness)3 – LV end-diastolic 
632  L. Vähämurto et al.
diameter)3] + 0.6 g (see [16]). LV mass was indexed 
according to subject’s height using the allometric 
power of 2.7 (indexed LV mass=LV mass/height2.7) 
since this indexation has been shown to perform better 
for obese subjects [17].
To calculate LV diastolic performance index, E/e′-
ratio, continuous and pulse-wave Doppler were used 
to measure transmitral flow and tissue velocities as 
described earlier [14]. E/e′-ratio is calculated from 
transmitral flow and myocardial tissue velocities, 
lower E/e′ indicating more favourable LV diastolic 
function [10,14]. For e′, the mean of lateral e′ and 
medial e′ was used. A single outlying value of E/e′-
ratio (over 11) was excluded from the analyses.
Cardiovascular risk factors
Weight and height were measured and body mass index 
(BMI) was calculated (kg/m2). Blood pressure in 1980 
and 2011 was measured with a random zero sphyg-
momanometer except for 3-year-old subjects (1980) 
for whom an ultrasonic device was used (Arteriosonde, 
Roche). An average of three measurements was used. 
Venous blood samples were drawn after an overnight 
fast and analyzed with standard enzymatic methods to 
determine serum lipids and glucose [13]. Information 
on parental socioeconomic status (SES; annual income 
index ranging from 1 to 8, higher indicating higher 
income) in 1980, subject’s birth weight, and physical 
activity in childhood and in adulthood were obtained 
with questionnaires. A physical activity index was calcu-
lated, lower scores indicating lower activity level [18]. 
Since the physical activity index was different for chil-
dren and adolescents/adults at baseline, these index val-
ues were Z-scored by age and sex.
Statistical analyses
Differences in characteristics of the study subjects at 
baseline were analyzed with an independent samples 
t-test. Association of LV mass, E/e′-ratio, EF, LV end-
diastolic volume and LA end-systolic volume with 
eastern/western baseline origin (also with current 
residency and family origin for LV mass and E/e′) 
were analyzed with an age- and sex-adjusted analysis 
of covariance (ANCOVA). There were no significant 
sex*geographic origin interactions. Mean, SE and 
p-values were calculated with adjustment for age, sex 
and area of examination in 2011, and for LVM and 
E/e′ additionally baseline and current CHD risk fac-
tors were used as covariates. Birthweight, BMI, sys-
tolic blood pressure, total cholesterol, parental SES 
and physical activity at baseline and BMI, systolic 
blood pressure, total cholesterol, plasma glucose, 
prevalence of smoking, own SES and physical activity 
at the time of the echocardiography (2011) were cho-
sen as the covariates since these risk factors are known 
to associate with LV mass and in the data we have 
previously found an east–west difference in these risk 
factors [4,19]. The analyses were performed with 
SAS version 9.3 (SAS institute, Inc, Cary, NC). 
Values of p<0.05 were considered significant.
Results
Characteristics at baseline and in 2011
Baseline (1980) and current characteristics of the 
study subjects according to eastern or western place 
of residency are shown in Table I. There was no east–
west difference in sex distribution (east 54.8% 
women vs. west 54.2% women, p=0.78) or age. 
Subjects living in the east had a higher systolic and 
diastolic blood pressure and low-density lipoprotein 
(LDL) cholesterol concentration than subjects living 
in the west. At baseline, parental SES (income index) 
was higher in western than among eastern subjects. 
In 2011, subjects who lived in eastern Finland at 
baseline were shorter than subjects who lived in west-
ern Finland at baseline. No other east–west differ-
ences in characteristics were found in 2011.
Echocardiographic measurements
Echocardiographic measurements according to base-
line (1980) origin are shown in Table II (adjusted for 
age, sex and area of examination in 2011). Subjects 
with eastern baseline origin had higher LV mass, 
indexed LV mass and lower ejection fraction than 
subjects with western origin. Concerning diastolic 
function, subjects with baseline origin in east had 
higher E/e′-ratio and LV end-diastolic volume but no 
difference in left atrial end-systolic volume.
Left ventricular mass
The mean±SD for LV mass in men was 158±33 g 
and with allometric index 32.5±6.9 g/m2.7 (N=862). 
In women the mean±SD for LV mass and indexed 
LV mass were 115±33 g and 29.4±6.1 g/m2.7, respec-
tively (N=1045). Indexed LV mass according to east-
ern/western baseline origin, current residency and 
family origin is shown in Figure 1a (adjusted for age, 
sex and area of examination in 2011). In all compari-
sons, the eastern subjects had higher indexed LV 
mass compared to their western peers. The most pro-
nounced east–west difference in LV mass was found 
when the subjects were studied according their cur-
rent place of residency. There was no sex*geographic 
origin interaction, indicating that the results were 
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similar for men and women. We further analyzed 
east–west differences in indexed LV mass by addi-
tionally adjusting for CHD risk factors at baseline 
(birthweight, BMI, systolic blood pressure, total cho-
lesterol, parental SES, physical activity) and current 
risk factors (BMI, systolic blood pressure, total cho-
lesterol, plasma glucose, smoking, own SES and 
physical activity) (Figure 1b). With these adjust-
ments, the east–west differences persisted between 
subjects according to their family origin, baseline ori-
gin and current place of residency.
Diastolic function (E/e′)
Among all subjects the average E/e′-ratio was 4.6±1.0 
in men (N=887) and 5.0±1.0 in women (N=1051). 
The E/e′-ratio according to eastern/western baseline 
origin, current residency or family origin is shown in 
Figure 2a. The western subjects had more effective 
diastolic function than their eastern peers according to 
baseline origin, current residency and family origin. 
There was no sex*geographic origin interaction indi-
cating that the results were similar for men and women. 
To examine the independent association between geo-
graphic origin and E/e′-ratio, we included CHD risk 
factors at baseline (birthweight, BMI, systolic blood 
pressure, total cholesterol, parental SES, physical activ-
ity) and currently (BMI, systolic blood pressure, total 
cholesterol, plasma glucose, smoking, own SES and 
physical activity) into the analyses (Figure 2b). With 
this model, the east–west difference in E/e′-ratio 
according to family origin was no longer significant.
Table I. Characteristics of the study subjects at baseline (1980) and in 2011, mean ± SE.
Men Women p total *
(East/West)
 East West East West  
 N Mean±SD N Mean±SD N Mean±SD N Mean±SD
Baseline  
Age, y 434 10.8±5.0 496 10.8±5.1 527 11.2±4.9 588 10.75.0 0.20
Height, cm 429 145±27 491 146±28 524 143±24 588 141±24 0.001
BMI, kg/m2 429 17.9±2.8 491 18.2±3.5 522 18.0±3.0 588 17.8±3.1 0.93
Systolic blood pressure, mmHg 428 114±13 490 113±13 522 114±11 588 111±11 <0.0001
Diastolic blood pressure, mmHg 369 71±9 417 67±10 460 70±8 507 67±10 <0.0001
LDL- cholesterol, mmol/l 431 3.41±0.84 490 3.34 ±0.79 520 3.56±0.95 581 3.41±0.79 <0.0001
Parental income (range 1 to 8) 419 4.7±2.0 478 5.1±1.8 513 4.7±2.1 564 5.1±1.8 <0.0001
2011  
Age, y 434 41.8±5.0 496 41.8±5.1 527 42.2±4.9 588 41.7±5.0 0.94
Height, cm 433 179±7 493 180±7 523 165±6 583 167±6 0.001
BMI, kg/m² 433 27.0±4.1 492 27.0±4.6 523 26.0±5.4 582 26.2±5.6 0.76
Systolic blood pressure, mmHg 428 123±13 492 123±14 520 115±13 583 116±15 0.61
Diastolic blood pressure, mmHg 428 78±10 492 77±11 520 72±9 583 72±10 0.73
total cholesterol, mmol/L 434 5.31±0.99 496 5.33±1.03 527 5.11±0.89 588 5.04±0.88 0.47
HDL-cholesterol, mmol/L 415 1.19±0.28 477 1.21±0.31 524 1.43±0.32 582 1.43±0.33 0.71
LDL-cholesterol, mmol/L 434 3.45±0.91 494 3.42±0.89 527 3.17±0.74 588 3.12±0.76 0.29
Smokers (%) 407 19.4 457 15.3 509 13.4 560 12.5 0.16
*For p-value, men and women were analyzed together.







 Mean ± SE Mean ± SE
LV mass, g 139± 1.0 135± 1.0 0.006
LV mass, indexed, g/m2.7 31.5± 0.2 30.4± 0.2 0.001
Ejection fraction, % 58.1± 0.1 58.4± 0.1 0.04
Left atrium end-systolic volume, ml 43.4± 0.5 44.0± 0.5 0.45
LV end-diastolic volume, ml 135± 0.9 131± 0.9 0.001
E/e′- ratio 4.86± 0.03 4.74± 0.03 0.02
634  L. Vähämurto et al.
Discussion
We found that 34–49-year-old subjects with baseline 
origin or current residency in east Finland had a 
higher LV mass and higher E/e′- ratio, indicating 
more adverse diastolic function, than subjects with 
baseline origin or current residency in western 
Finland. These associations were independent of 
childhood and adulthood CHD risk factors. Of note, 
most of our middle-aged population was well within 
the normal limits for LV mass and E/e′.
LV hypertrophy is an indicator of future cardio-
vascular events [7, 20]. The Framingham Heart 
Study was a groundbreaking study to show a contin-
uous relation between LV mass and CV event rate in 
the general population [21]. The pathogenesis of LV 
hypertrophy initiates usually with essential arterial 
hypertension and reduction in blood pressure is 
marked with regression of LV hypertrophy [22].
Historically, eastern Finns have had higher CHD 
mortality rates than western Finns in the 1960s [1]. 
The excessive risk was associated with higher CHD 
risk factor levels in the east. A national intervention 
called the North Karelia project was launched in the 
1970s to lower CHD risk factors by targeting diet 
and other lifestyle factors especially in eastern 
Finland [3].The CHD mortality in eastern Finland 
has declined significantly over decades, and the 
decline has been explained with the decrease in risk 
factors [23]. In our previous study [4] and other 
studies [24], the east–west difference in CHD risk 
factors had almost disappeared.
In spite the changes in CHD risk factors, eastern 
Finns have had higher carotid IMT compared to 
western Finns [25], as reported also in our recent 
study [4]. The results of the present study showing 
higher LV mass among eastern Finns are logical with 
earlier findings of higher IMT in the east as both are 
dependent on cardiovascular risk factors. Together 
these results suggest there might be a persisting 
increased risk for cardiovascular diseases in eastern 
Finns compared with western Finns also in the future 
despite the risk factor levels are evening out.
Elevated LV mass may contribute to the develop-
ment of diastolic dysfunction [26] although LV mass 
may also be normal in patients with poor diastolic 
function [27]. LV diastolic dysfunction often occurs 
with normal systolic function, and this condition is 
Figure 1. LV mass (allometric index, mean and SE).
(a) for subjects with baseline origin in east (N=902) / west 
(N=1005), current residency in east (N=653) / west (N=1254), 
family origin in east (N=672) / west (N=401); adjusted for age, sex 
and area of examination in 2011.
(b) for subjects with baseline origin in east (N=645) / west 
(N=745), current residency in east (N=465) / west (N=925), fam-
ily origin in east (N=499) / west (N=309); adjusted for age, sex, 
examination area in 2011, risk factors at baseline (BMI, systolic 
blood pressure, total cholesterol, birthweight, parental SES, physi-
cal activity) and currently (BMI, systolic blood pressure, total 
cholesterol, plasma glucose, prevalence of smoking, own SES and 
physical activity).
Figure 2. E/e′ - ratio (mean and SE).
(a) for subjects with baseline origin in east (N=920) / west 
(N=1017), current residency in east (N=680)/ west (N=1257), 
family origin in east (N=684) / west (N=407), adjusted for age, 
sex and area of examination in 2011.
(b) for subjects with baseline origin in east (N=655) / west (N=752), 
current residency in east (N=484) / west (N=923), family origin in 
east (N=505) / west (N=312), adjusted for age, sex, examination 
area in 2011, risk factors at baseline (BMI, systolic blood pressure, 
total cholesterol, birthweight, parental SES, physical activity) and 
currently (BMI, systolic blood pressure, total cholesterol, plasma 
glucose, prevalence of smoking, own SES and physical activity).
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referred to as heart failure with preserved ejection 
fraction. It is a common clinical syndrome with high 
morbidity and mortality [28]. E/e′ is an appropriate 
noninvasive indicator of increased LV end-diastolic 
pressure in patients with heart failure with preserved 
ejection fraction [10]. In a study with hypertensive 
DOCA-salt treated porcine, especially e′ was shown 
to increase experimentally in rest and during dobu-
tamine-induced stress [29]. Furthermore, E/e′-ratio 
indicates LV end-diastolic pressure regarding dias-
tolic dysfunction [30,31], and in a hypertensive pop-
ulation it may predict primary cardiac events even 
better than LV mass [32].
In addition to E/e′-ratio, LV diastolic function is 
related to LV end-diastolic volume [8]. In this study 
both E/e′- ratio and LV end-diastolic volume were 
higher among subjects with eastern baseline origin 
compared to western subjects, thus indicating less 
effective diastolic function among eastern Finns. 
Another marker of LV diastolic dysfunction, the vol-
ume of LA remained unchanged. This is probably 
explained by the young age of the study group when 
considering cardiovascular events. The volume 
change of the LA needs longer exposure time to 
develop then change in the E/e′-ratio [11] [12].
Genetic differences have been suggested to explain 
part of the difference in CHD risk between eastern 
and western Finns [33]. We found eastern family ori-
gin associating with higher LV mass and diastolic 
function, in line with previously reported higher 
carotid IMT and lower brachial flow-mediated dila-
tion in subjects with eastern family origin compared 
to western family origin [19]. The effect of family ori-
gin might also be due to inherited health behavior 
differences or epigenetics. In this study, the subject’s 
current residency was not controlled in the analyses 
of family origin and may thus affect the association of 
the family origin with LV mass and diastolic func-
tion. Further investigation is needed to better under-
stand the underlying factors in CHD risk related to 
family origin.
The east–west differences in LV mass and E/e′ 
were greater according to current place of residency 
than according to baseline origin. This finding sug-
gests that migration has contributed to east–west dif-
ferences in LV mass and diastolic function. Our 
previous study showed that 27% of subjects who 
lived in eastern Finland in 1980 had moved to west 
by 2007 whereas only 2% moved of those who lived 
in western Finland in in 1980 had moved to east by 
2007 [4]. The subjects who migrated east-to-west 
had lower carotid IMT than subjects who continu-
ously lived in eastern Finland [4]. Our current study 
lends support to prior results that migration influ-
ences east–west differences in surrogate markers of 
cardiovascular diseases, likely increasing the observed 
differences.
To the best of the authors’ knowledge, similar 
reports to this study from other countries are scarce. 
In addition to Finland, geographic difference in LV 
mass has been found earlier in Germany, where sub-
jects from the northeast had higher LV mass than 
subjects from the southwestern part of the country 
[34]. A systematic review of 33 studies from different 
countries showed that normal values for LV mass dif-
fer largely between different nations and ethnicities 
worldwide [35].
The study has some limitations. Cardiac ultra-
sonography has been performed only at one time 
point, thus longitudinal estimation of change in car-
diac shape cannot be made. LV mass can be meas-
ured more precisely with cardiac magnetic resonance 
than with transthoracic echocardiography as applied 
in this study [36]. To model diastolic function, a 
strain-analysis would have been even more accurate 
than the measurements available in this study [37]. 
Ejection fraction was calculated from measure-
ments made in a single plane. Despite the east–west 
differences in LV mass and E/e′-ratio, the majority 
of our study population is well within the normal 
values of these echocardiographic measurements. 
Thus, it is too early to say whether east–west differ-
ences in the prevalence of actual LV hypertrophy 
and diastolic dysfunction will be seen. Furthermore, 
it is unknown whether any baseline differences in 
left ventricular structure and function existed. 
Adjustment for baseline and current CHD risk fac-
tors did not attenuate the differences in LV mass 
and E/e′- ratio between subjects with eastern and 
western baseline origin. Our model with adjustment 
for risk factors at two time-points might not be 
robust enough to dilute these differences, especially 
as current east–west differences in risk factors are 
nearly non-existent. In longitudinal studies, it is 
inevitable that loss to follow-up occurs. However, 
we have found that risk factor levels are essentially 
similar among participants and non-participants at 
baseline [13]. Long follow-up extending 30 years, 
detailed phenotyping of the participants and the 
prospective study design are the evident strengths of 
this study.
In conclusion, we found higher LV mass and E/e′- 
ratio indicating weaker diastolic function in eastern 
Finns compared to western Finns, independently of 
baseline and current risk factors. Most of the subjects 
were still well within normal limits, but the findings 
suggest we might observe higher prevalence of LV 
hypertrophy and diastolic dysfunction in subjects 
with eastern geographic origin compared to subjects 
with western geographic origin.
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